159 related articles for article (PubMed ID: 20404506)
1. SKI promotes Smad3 linker phosphorylations associated with the tumor-promoting trait of TGFbeta.
Lin Q; Chen D; Timchenko NA; Medrano EE
Cell Cycle; 2010 May; 9(9):1684-9. PubMed ID: 20404506
[TBL] [Abstract][Full Text] [Related]
2. SKI knockdown inhibits human melanoma tumor growth in vivo.
Chen D; Lin Q; Box N; Roop D; Ishii S; Matsuzaki K; Fan T; Hornyak TJ; Reed JA; Stavnezer E; Timchenko NA; Medrano EE
Pigment Cell Melanoma Res; 2009 Dec; 22(6):761-72. PubMed ID: 19845874
[TBL] [Abstract][Full Text] [Related]
3. Repression of TGF-beta signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis.
Medrano EE
Oncogene; 2003 May; 22(20):3123-9. PubMed ID: 12793438
[TBL] [Abstract][Full Text] [Related]
4. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression.
Javelaud D; van Kempen L; Alexaki VI; Le Scolan E; Luo K; Mauviel A
Mol Cancer; 2011 Jan; 10(1):2. PubMed ID: 21211030
[TBL] [Abstract][Full Text] [Related]
5. c-Ski inhibits the proliferation of vascular smooth muscle cells via suppressing Smad3 signaling but stimulating p38 pathway.
Li J; Li P; Zhang Y; Li GB; Zhou YG; Yang K; Dai SS
Cell Signal; 2013 Jan; 25(1):159-67. PubMed ID: 22986000
[TBL] [Abstract][Full Text] [Related]
6. Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes.
Kim KO; Sampson ER; Maynard RD; O'Keefe RJ; Chen D; Drissi H; Rosier RN; Hilton MJ; Zuscik MJ
J Cell Biochem; 2012 Jun; 113(6):2156-66. PubMed ID: 22461172
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of action of acetaldehyde in the up-regulation of the human α2(I) collagen gene in hepatic stellate cells: key roles of Ski, SMAD3, SMAD4, and SMAD7.
Reyes-Gordillo K; Shah R; Arellanes-Robledo J; Hernández-Nazara Z; Rincón-Sánchez AR; Inagaki Y; Rojkind M; Lakshman MR
Am J Pathol; 2014 May; 184(5):1458-67. PubMed ID: 24641900
[TBL] [Abstract][Full Text] [Related]
8. Requirement of a dynein light chain in TGFbeta/Smad3 signaling.
Jin Q; Gao G; Mulder KM
J Cell Physiol; 2009 Dec; 221(3):707-15. PubMed ID: 19711352
[TBL] [Abstract][Full Text] [Related]
9. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
Ferrand N; Atfi A; Prunier C
Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling.
Reed JA; Bales E; Xu W; Okan NA; Bandyopadhyay D; Medrano EE
Cancer Res; 2001 Nov; 61(22):8074-8. PubMed ID: 11719430
[TBL] [Abstract][Full Text] [Related]
11. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.
Akiyoshi S; Inoue H; Hanai J; Kusanagi K; Nemoto N; Miyazono K; Kawabata M
J Biol Chem; 1999 Dec; 274(49):35269-77. PubMed ID: 10575014
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling.
Sun Y; Liu X; Eaton EN; Lane WS; Lodish HF; Weinberg RA
Mol Cell; 1999 Oct; 4(4):499-509. PubMed ID: 10549282
[TBL] [Abstract][Full Text] [Related]
13. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
[TBL] [Abstract][Full Text] [Related]
14. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
[TBL] [Abstract][Full Text] [Related]
15. Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma.
Abushahba W; Olabisi OO; Jeong BS; Boregowda RK; Wen Y; Liu F; Goydos JS; Lasfar A; Cohen-Solal KA
PLoS One; 2012; 7(10):e47312. PubMed ID: 23077590
[TBL] [Abstract][Full Text] [Related]
16. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation.
Prunier C; Pessah M; Ferrand N; Seo SR; Howe P; Atfi A
J Biol Chem; 2003 Jul; 278(28):26249-57. PubMed ID: 12732634
[TBL] [Abstract][Full Text] [Related]
17. SKI activates Wnt/beta-catenin signaling in human melanoma.
Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
[TBL] [Abstract][Full Text] [Related]
18. Expression and localization of Ski determine cell type-specific TGFbeta signaling effects on the cell cycle.
Jacob C; Grabner H; Atanasoski S; Suter U
J Cell Biol; 2008 Aug; 182(3):519-30. PubMed ID: 18695043
[TBL] [Abstract][Full Text] [Related]
19. Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer.
Yang H; Zhan L; Yang T; Wang L; Li C; Zhao J; Lei Z; Li X; Zhang HT
Oncol Rep; 2015 Jul; 34(1):87-94. PubMed ID: 25955797
[TBL] [Abstract][Full Text] [Related]
20. Modulation of TGFβ/Smad signaling by the small GTPase RhoB.
Livitsanou M; Vasilaki E; Stournaras C; Kardassis D
Cell Signal; 2018 Aug; 48():54-63. PubMed ID: 29705334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
